Dexamethasone + Prednisolone + FARLETUZUMAB ECTERIBULIN + Prednisone

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Dexamethasone + Prednisolone + FARLETUZUMAB ECTERIBULIN + Prednisone
Treatment and conditionWhere it standsTrials
Dexamethasone + Prednisolone + FARLETUZUMAB ECTERIBULIN + Prednisone for adenocarcinomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexamethasone + Prednisolone + FARLETUZUMAB ECTERIBULIN + Prednisone for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1